Form 4: Schrodinger Executive Yvonne Tran Reports Stock and Option Awards
SEC Form 4 Filing
EVP, CLO & CPO of Schrodinger, Inc., Yvonne Tran, reports the acquisition of restricted stock units and stock options.
Summary
- On March 3, 2025, Yvonne Tran, EVP, CLO & CPO of Schrodinger, Inc., was granted 12,500 restricted stock units (RSUs) and an option to purchase 50,000 shares of common stock.
- The RSUs will vest in equal installments on March 4 of 2026, 2027, 2028, and 2029, contingent upon continued service with the company.
- The stock options, with an exercise price of $21.24, vest 25% on March 3, 2026, and the remainder in equal monthly installments through March 3, 2029.
- Following these transactions, Tran beneficially owns 23,635 shares of common stock, including 16,295 unvested RSUs, and options to purchase 50,000 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices, incentivizing long-term commitment. There are no immediate negative implications.
Positives
- The grant of RSUs and stock options to a key executive like Yvonne Tran aligns her interests with those of the shareholders.
- The vesting schedules for both RSUs and stock options incentivize long-term commitment and performance.
Industry Context
Stock and option awards are a common practice in the biotech and tech industries to attract, retain, and incentivize key executives. The vesting schedules are designed to align executive compensation with long-term company performance.
Comparison to Industry Standards
- Stock option grants with multi-year vesting schedules are standard practice among publicly traded companies, particularly in the technology and biotechnology sectors.
- Companies like Moderna and BioNTech also utilize similar equity-based compensation plans for their executives.
- The vesting schedule of 25% after one year followed by monthly installments is a fairly typical structure to ensure continued service and commitment.
Stakeholder Impact
- Shareholders may view the equity grants positively as they align management's interests with the company's long-term success.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of grant for restricted stock units and stock options. |
| 03/04/2025 | Date of Form 4 filing. |
| 03/04/2026 | First vesting date for a portion of the restricted stock units. |
| 03/03/2026 | First vesting date for a portion of the stock options. |
| 03/03/2029 | Final vesting date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.